ADC Therapeutics SA (ADCT)
4.11
+0.07
(+1.73%)
USD |
NYSE |
May 15, 16:00
4.11
0.00 (0.00%)
After-Hours: 16:24
ADC Therapeutics Total Assets (Quarterly): 307.97M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 307.97M |
| December 31, 2023 | 354.78M |
| September 30, 2023 | 466.90M |
| June 30, 2023 | 507.30M |
| March 31, 2023 | 467.67M |
| December 31, 2022 | 490.86M |
| September 30, 2022 | 531.76M |
| June 30, 2022 | 520.46M |
| March 31, 2022 | 581.89M |
| December 31, 2021 | 617.97M |
| Date | Value |
|---|---|
| September 30, 2021 | 637.98M |
| June 30, 2021 | 464.39M |
| March 31, 2021 | 461.70M |
| December 31, 2020 | 513.69M |
| September 30, 2020 | 521.53M |
| June 30, 2020 | 373.84M |
| December 31, 2019 | 137.68M |
| June 30, 2019 | 200.84M |
| December 31, 2018 | 150.56M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
137.68M
Minimum
Dec 2019
637.98M
Maximum
Sep 2021
453.29M
Average
479.27M
Median
Total Assets (Quarterly) Benchmarks
| Roche Holding AG | 107.71B |
| Novartis AG | 94.33B |
| AC Immune SA | 185.40M |
| CRISPR Therapeutics AG | 2.439B |
| Addex Therapeutics Ltd | 5.526M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 502.42M |
| Shareholders Equity (Quarterly) | -194.45M |
| Debt to Equity Ratio | -0.5823 |
| Current Ratio | 4.608 |
| Net Debt Paydown Yield | -0.19% |